2021
DOI: 10.7554/elife.70412
|View full text |Cite
|
Sign up to set email alerts
|

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Abstract: Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease, which warrants the critical need to identify new therapeutic targets. We show that Zinc Fingers and Homeoboxes 2 (ZHX2) is amplified or overexpressed in TNBC cell lines and patients. Functionally, depletion of ZHX2 inhibited TNBC cell growth and invasion in vitro, orthotopic tumor growth and spontaneous lung metastasis in vivo. Mechanistically, ZHX2 bound with hypoxia inducible factor (HIF) family members and positively regulated … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 70 publications
0
21
0
Order By: Relevance
“…[ 49 ] In contrast to these tumors, Zhx2 is oncogenic in clear‐cell renal cell carcinoma, the most common kidney tumor, potentially through co‐regulation of target genes with NF‐κB, [ 50 ] and in triple‐negative breast cancer, where it co‐regulates target genes with hypoxia inducible factor 1 alpha subunit. [ 51 ] Future studies will require different liver tumor model systems to fully understand Zhx2 control of tumor initiation and promotion. Because Zhx2 is known to regulate many genes that control lipid homeostasis, and that obesity and NAFLD are currently major drivers of the increased incidence of HCC, it will be particularly interesting to investigate the role of Zhx2 in high‐fat diet–induced liver tumor models.…”
Section: Discussionmentioning
confidence: 99%
“…[ 49 ] In contrast to these tumors, Zhx2 is oncogenic in clear‐cell renal cell carcinoma, the most common kidney tumor, potentially through co‐regulation of target genes with NF‐κB, [ 50 ] and in triple‐negative breast cancer, where it co‐regulates target genes with hypoxia inducible factor 1 alpha subunit. [ 51 ] Future studies will require different liver tumor model systems to fully understand Zhx2 control of tumor initiation and promotion. Because Zhx2 is known to regulate many genes that control lipid homeostasis, and that obesity and NAFLD are currently major drivers of the increased incidence of HCC, it will be particularly interesting to investigate the role of Zhx2 in high‐fat diet–induced liver tumor models.…”
Section: Discussionmentioning
confidence: 99%
“…Zhx2 inhibits the metastatic potential of several thyroid cancer cell lines, possibly by inhibition of S100A14, suggesting a tumor suppressor role in this cancer (49). In contrast to these tumors, Zhx2 is oncogenic in clear cell Renal Cell Carcinoma, the most common kidney tumor, potentially through co-regulation of target genes with NF-κB (50), and in triple-negative breast cancer, where it co-regulates target genes with HIF1a (51). Future studies will require different liver tumor model systems to fully understand Zhx2 control of tumor initiation and promotion.…”
Section: Discussionmentioning
confidence: 99%
“…Given an importance of hypoxia signaling in tumor progression and cell metabolism, the present studies are mainly focused on investigating the effects of HIF1α binding partners in affecting these processes ( 65 ) ( 19 , 58 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 ). In fact, the roles of hypoxia signaling in hypoxia adaptation and tolerance have been noticed, particularly for high-altitude adaptation ( 77 , 78 , 79 , 80 , 81 ).…”
Section: Discussionmentioning
confidence: 99%